Home / Inspections / 822994

FDA Inspection 822994 — Amphastar France Pharmaceuticals

Amphastar France Pharmaceuticals — FEI 3003672088

The FDA completed an inspection of Amphastar France Pharmaceuticals on February 7, 2013 in Eragny Sur Epte. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 7, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Eragny Sur Epte (France)

Facility

Other inspections at this facility

  • 1206214 (VAI Fri Nov 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1061143 (VAI Fri Jun 29 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 964572 (VAI Fri Mar 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 665559 (VAI Tue Mar 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 625848 (NAI Tue Oct 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources